446 related articles for article (PubMed ID: 25743330)
1. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
[TBL] [Abstract][Full Text] [Related]
2. Tissue Expression of Melanoma-associated Antigen A6 and Clinical Characteristics of Gastric Cancer.
Endo M; Kanda M; Sawaki K; Shimizu D; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Yamada S; Koike M; Omae K; Kodera Y
Anticancer Res; 2019 Nov; 39(11):5903-5910. PubMed ID: 31704814
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
[TBL] [Abstract][Full Text] [Related]
4. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
Shi R; Wang L; Wang T; Xu J; Wang F; Xu M
Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
[TBL] [Abstract][Full Text] [Related]
5. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
[TBL] [Abstract][Full Text] [Related]
6. High expression levels of MAGE-A9 are correlated with unfavorable survival in lung adenocarcinoma.
Zhai X; Xu L; Zhang S; Zhu H; Mao G; Huang J
Oncotarget; 2016 Jan; 7(4):4871-81. PubMed ID: 26717042
[TBL] [Abstract][Full Text] [Related]
7. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
[TBL] [Abstract][Full Text] [Related]
8. TPX2 expression is associated with poor survival in gastric cancer.
Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036
[TBL] [Abstract][Full Text] [Related]
9. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
10. Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer.
Dang Y; Lan F; Ouyang X; Wang K; Lin Y; Yu Y; Wang L; Wang Y; Huang Q
World J Surg Oncol; 2015 Oct; 13():302. PubMed ID: 26472090
[TBL] [Abstract][Full Text] [Related]
11. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.
Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y
J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner.
Ertao Z; Jianhui C; Kang W; Zhijun Y; Hui W; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C
Tumour Biol; 2016 Oct; 37(10):13679-13685. PubMed ID: 27473085
[TBL] [Abstract][Full Text] [Related]
13. The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance.
Lu G; Zhou L; Zhang X; Zhu B; Wu S; Song W; Gong X; Wang D; Tao Y
World J Surg Oncol; 2016 Oct; 14(1):276. PubMed ID: 27793161
[TBL] [Abstract][Full Text] [Related]
14. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of β2-adrenergic receptor expression in patients with surgically resected gastric adenocarcinoma.
Takahashi K; Kaira K; Shimizu A; Sato T; Takahashi N; Ogawa H; Yoshinari D; Yokobori T; Asao T; Takeyoshi I; Oyama T
Tumour Biol; 2016 Oct; 37(10):13885-13892. PubMed ID: 27485115
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
Jang BG; Lee BL; Kim WH
Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
[TBL] [Abstract][Full Text] [Related]
17. MAGE-A family is involved in gastric cancer progression and indicates poor prognosis of gastric cancer patients.
Lian Y; Sang M; Gu L; Liu F; Yin D; Liu S; Huang W; Wu Y; Shan B
Pathol Res Pract; 2017 Aug; 213(8):943-948. PubMed ID: 28647208
[TBL] [Abstract][Full Text] [Related]
18. Expression of SIP1 is strongly correlated with LDHA and shows a significantly poor outcome in gastric cancer.
Sun X; Sun Z; Zhu Z; Li C; Zhang J; Xu H; Sun M
Tumour Biol; 2015 Sep; 36(10):7521-30. PubMed ID: 25913622
[TBL] [Abstract][Full Text] [Related]
19. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.
Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of CrkL as a novel biomarker for poor prognosis in gastric cancer.
Feng R; Li J; Sah BK; Yuan F; Jin X; Yan M; Liu B; Li C; Zhu Z
Cancer Biomark; 2019; 26(2):131-138. PubMed ID: 31356198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]